Active recombinant Tol2 transposase for gene transfer and gene discovery applications

被引:20
|
作者
Ni, Jun [1 ,2 ]
Wangensteen, Kirk J. [3 ,4 ]
Nelsen, David [3 ]
Balciunas, Darius [3 ,5 ]
Skuster, Kimberly J. [1 ]
Urban, Mark D. [1 ]
Ekker, Stephen C. [1 ]
机构
[1] Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW,1342C Guggenheim, Rochester, MN 55905 USA
[2] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA
[3] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA
[4] Univ Penn, 9 Penn Tower,3400 Spruce ST, Philadelphia, PA 19104 USA
[5] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA
来源
MOBILE DNA | 2016年 / 7卷
基金
美国国家卫生研究院;
关键词
Tol2; transposase; hAT superfamily; Recombinant transposase protein; Zebrafish; Transposition site preference; TARGET SITE SELECTION; SLEEPING-BEAUTY; MEDAKA FISH; HUMAN-CELLS; T-CELLS; IN-VIVO; ZEBRAFISH; ELEMENT; PIGGYBAC; IDENTIFICATION;
D O I
10.1186/s13100-016-0062-z
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: The revolutionary concept of "jumping genes" was conceived by McClintock in the late 1940s while studying the Activator/Dissociation (Ac/Ds) system in maize. Transposable elements (TEs) represent the most abundant component of many eukaryotic genomes. Mobile elements are a driving force of eukaryotic genome evolution. McClintock's Ac, the autonomous element of the Ac/Ds system, together with hobo from Drosophila and Tam3 from snapdragon define an ancient and diverse DNA transposon superfamily named hAT. Other members of the hAT superfamily include the insect element Hermes and Tol2 from medaka. In recent years, genetic tools derived from the 'cut' and 'paste' Tol2 DNA transposon have been widely used for genomic manipulation in zebrafish, mammals and in cells in vitro. Results: We report the purification of a functional recombinant Tol2 protein from E. coli. We demonstrate here that following microinjection using a zebrafish embryo test system, purified Tol2 transposase protein readily catalyzes gene transfer in both somatic and germline tissues in vivo. We show that purified Tol2 transposase can promote both in vitro cutting and pasting in a defined system lacking other cellular factors. Notably, our analysis of Tol2 transposition in vitro reveals that the target site preference observed for Tol2 in complex host genomes is maintained using a simpler target plasmid test system, indicating that the primary sequence might encode intrinsic cues for transposon integration. Conclusions: This active Tol2 protein is an important new tool for diverse applications including gene discovery and molecular medicine, as well as for the biochemical analysis of transposition and regulation of hAT transposon/genome interactions. The measurable but comparatively modest insertion site selection bias noted for Tol2 is largely determined by the primary sequence encoded in the target sequence as assessed through studying Tol2 protein-mediated transposition in a cell-free system.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Tol2 Transposon as a Gene Therapy Vector: Characterization, Optimization and Correction of Hereditary Tyrosinemia Type 1 in Mouse
    Balciunas, Darius
    Wilber, Andrew
    Wangensteen, Kirk
    Bell, Jason
    Geurts, Aron
    Hackett, Perry B.
    Largaespada, David A.
    McIvor, R. Scott
    Ekker, Stephen C.
    MOLECULAR THERAPY, 2006, 13 : S147 - S147
  • [22] Evidence of horizontal gene transfer by transposase gene analyses in Fervidobacterium species
    Cuecas, Alba
    Kanoksilapatham, Wirojne
    Gonzalez, Juan M.
    PLOS ONE, 2017, 12 (04):
  • [23] Generation of transgenic fish cell line with a-lactalbumin nanocarriers co-delivering Tol2 transposase mRNA and plasmids
    Zhao, Ran
    Zhang, Yan
    Wang, Qi
    Cao, Yi-Ming
    Hou, Ming-Xi
    Sun, Xiao-Qing
    Yu, Shuang-Ting
    Chen, Ying-Jie
    Wang, Kai-Kuo
    Li, Jiong-Tang
    ISCIENCE, 2024, 27 (08)
  • [24] Real-time monitoring of circadian clock oscillations in primary cultures of mammalian cells using Tol2 transposon-mediated gene transfer strategy
    Yagita, Kazuhiro
    Yamanaka, Iori
    Emoto, Noriaki
    Kawakami, Koichi
    Shimada, Shoichi
    BMC BIOTECHNOLOGY, 2010, 10
  • [25] Real-time monitoring of circadian clock oscillations in primary cultures of mammalian cells using Tol2 transposon-mediated gene transfer strategy
    Kazuhiro Yagita
    Iori Yamanaka
    Noriaki Emoto
    Koichi Kawakami
    Shoichi Shimada
    BMC Biotechnology, 10
  • [26] Amino acid sequence of a putative transposase protein of the medaka fish transposable element Tol2 deduced from mRNA nucleotide sequences
    Koga, A
    Suzuki, M
    Maruyama, Y
    Tsutsumi, M
    Hori, H
    FEBS LETTERS, 1999, 461 (03) : 295 - 298
  • [27] Genetic dissection of neural circuits by Tol2 transposon-mediated Gal4 gene and enhancer trapping in zebrafish
    Asakawa, Kazuhide
    Suster, Maximiliano L.
    Mizusawa, Kanta
    Nagayoshi, Saori
    Kotani, Tomoya
    Urasaki, Akihiro
    Kishimoto, Yasuyuki
    Hibi, Masahiko
    Kawakami, Koichi
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (04) : 1255 - 1260
  • [28] Identification of a functional transposase of the Tol2 element, an Ac-like element from the Japanese medaka fish, and its transposition in the zebrafish germ lineage
    Kawakami, K
    Shima, A
    Kawakami, N
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (21) : 11403 - 11408
  • [29] Genome-wide target profiling of piggyBac and Tol2in HEK 293: pros and cons for gene discovery and gene therapy
    Yaa-Jyuhn J Meir
    Matthew T Weirauch
    Herng-Shing Yang
    Pei-Cheng Chung
    Robert K Yu
    Sareina C-Y Wu
    BMC Biotechnology, 11
  • [30] Gene Transfer Efficiency and Genome-Wide Integration Profiling of Sleeping Beauty, Tol2, and PiggyBac Transposons in Human Primary T Cells (vol 18, pg 1803, 2010)
    Huang, Xin
    Guo, Hongfeng
    Tammana, Syam
    Jung, Yong-Chul
    Mellgren, Emil
    Bassi, Preetinder
    Cao, Qing
    Tu, Zheng Jin
    Kim, Yeong C.
    Ekker, Stephen C.
    Wu, Xiaolin
    Wang, San Ming
    Zhou, Xianzheng
    MOLECULAR THERAPY, 2010, 18 (11) : 2038 - 2038